Literature DB >> 15599699

alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action.

I Dahlman1, P Eriksson, M Kaaman, H Jiao, C M Lindgren, J Kere, P Arner.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to investigate the effect of single-nucleotide polymorphisms (SNPs) in the gene encoding the human alpha(2)-Heremans-Schmid glycoprotein (AHSG) on obesity and insulin action in adipocytes.
METHODS: We screened 24 individuals for SNPs in AHSG. Six haplotype-tagging SNPs were genotyped in 188 lean and 176 obese otherwise healthy women for whom common blood chemistry phenotypes were also available. Adipocyte lipolysis and lipogenesis phenotypes were quantified in a subset of 117 lean and 174 obese women.
RESULTS: The -469T>G SNP, which is located in the 5' region of AHSG, was associated with insulin-mediated inhibition of lipolysis and stimulation of lipogenesis, as well as basal and 8-bromocyclic AMP-stimulated lipolysis. Three AHSG SNPs were associated with circulating levels of cholesterol. None of the six genotyped SNPs or inferred haplotypes were associated with BMI, calculated percent body fat, waist circumference, circulating levels of glucose or insulin, or homeostasis model assessment of insulin resistance, which was used as an estimate of in vivo insulin sensitivity. CONCLUSIONS/
INTERPRETATION: Our results are in agreement with a threshold model of susceptibility for insulin resistance and type 2 diabetes, in which specific genetic loci regulate intermediate molecular phenotypes. When an individual's set of susceptibility alleles at such loci exceeds a threshold, clinical disease occurs. Lipolysis in adipocytes appears to be a phenotype that is particularly sensitive to variation in AHSG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599699     DOI: 10.1007/s00125-004-1556-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

Authors:  A H Kissebah; G E Sonnenberg; J Myklebust; M Goldstein; K Broman; R G James; J A Marks; G R Krakower; H J Jacob; J Weber; L Martin; J Blangero; A G Comuzzie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Automated genotyping using the DNA MassArray technology.

Authors:  Christian Jurinke; Dirk van den Boom; Charles R Cantor; Hubert Köster
Journal:  Methods Mol Biol       Date:  2002

3.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

4.  A sequence assembly and editing program for efficient management of large projects.

Authors:  S Dear; R Staden
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms.

Authors:  W M Howell; M Jobs; U Gyllensten; A J Brookes
Journal:  Nat Biotechnol       Date:  1999-01       Impact factor: 54.908

Review 6.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.

Authors:  David Botstein; Neil Risch
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

7.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

Authors:  D Gallagher; M Visser; D Sepúlveda; R N Pierson; T Harris; S B Heymsfield
Journal:  Am J Epidemiol       Date:  1996-02-01       Impact factor: 4.897

8.  Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.

Authors:  X Lin; H D Braymer; G A Bray; D A York
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes.

Authors:  László Kalabay; Károly Cseh; Attila Pajor; Eva Baranyi; György M Csákány; Zsolt Melczer; Gábor Speer; Margit Kovács; György Siller; István Karádi; Gábor Winkler
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

10.  Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.

Authors:  P R Srinivas; A S Wagner; L V Reddy; D D Deutsch; M A Leon; A S Goustin; G Grunberger
Journal:  Mol Endocrinol       Date:  1993-11
View more
  15 in total

1.  Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity.

Authors:  Diego Pérez-Sotelo; Arturo Roca-Rivada; María Larrosa-García; Cecilia Castelao; Iván Baamonde; Javier Baltar; Ana Belen Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

2.  AHSG gene variant is associated with leanness among Swedish men.

Authors:  Catharina Lavebratt; Sofia Wahlqvist; Louise Nordfors; Johan Hoffstedt; Peter Arner
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

Review 3.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 4.  Fetuin-A: a novel link between obesity and related complications.

Authors:  J F Trepanowski; J Mey; K A Varady
Journal:  Int J Obes (Lond)       Date:  2014-12-03       Impact factor: 5.095

5.  Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren.

Authors:  Giuseppe Murdolo; Cristina Tortoioli; Federica Celi; Vittorio Bini; Francesco Papi; Annalisa Brozzetti; Alberto Falorni
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

Review 6.  The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.

Authors:  F Roshanzamir; M Miraghajani; M H Rouhani; M Mansourian; R Ghiasvand; S M Safavi
Journal:  J Endocrinol Invest       Date:  2017-06-22       Impact factor: 4.256

7.  A common haplotype in the G-protein-coupled receptor gene GPR74 is associated with leanness and increased lipolysis.

Authors:  Ingrid Dahlman; Andrea Dicker; Hong Jiao; Juha Kere; Lennart Blomqvist; Vanessa van Harmelen; Johan Hoffstedt; Knut Borch-Johnsen; Torben Jorgensen; Torben Hansen; Oluf Pedersen; Markku Laakso; Peter Arner
Journal:  Am J Hum Genet       Date:  2007-05-02       Impact factor: 11.025

8.  Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Authors:  Majken K Jensen; Richard A Jensen; Kenneth J Mukamal; Xiuqing Guo; Jie Yao; Qi Sun; Marilyn Cornelis; Yongmei Liu; Ming-Huei Chen; Jorge R Kizer; Luc Djoussé; David S Siscovick; Bruce M Psaty; Joseph M Zmuda; Jerome I Rotter; Melissa Garcia; Tamara Harris; Ida Chen; Mark O Goodarzi; Michael A Nalls; Margaux Keller; Alice M Arnold; Anne B Newman; Ron C Hoogeveen; Kathryn M Rexrode; Eric B Rimm; Frank B Hu; Vasan S Ramachandran; Ronit Katz; James S Pankow; Joachim H Ix
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 5.121

9.  Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables.

Authors:  Nagwa Abdallah Ismail; Shadia Ragab; Soha M Abd El Dayem; Abeer Abd Elbaky; Nehal Salah; Mona Hamed; Heba Assal; Hala Koura
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

10.  Fetuin-A induces cytokine expression and suppresses adiponectin production.

Authors:  Anita M Hennige; Harald Staiger; Corinna Wicke; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.